Qian YB - Search Results

1

CARD9 promotes cholangiocarcinoma by regulating the IL-17A/Hedgehog and the THEM4/AKT/mTOR signaling pathways.

Zhang T, Zhu LX, Sun QK, Chen LJ, Qian YB. Zhang T, et al. Among authors: qian yb. Int Immunopharmacol. 2024 Dec 25;143(Pt 2):113399. doi: 10.1016/j.intimp.2024.113399. Epub 2024 Oct 16. Int Immunopharmacol. 2024. PMID: 39418733

2

[Clinicopathological significance of aberrant methylation of the fragile histidine triad gene in patients with hepatocellular carcinoma].

Sun Y, Geng XP, Zhu LX, Xiong QR, Qian YB, Dong GY, Li XM. Sun Y, et al. Among authors: qian yb. Zhonghua Wai Ke Za Zhi. 2006 May 1;44(9):609-12. Zhonghua Wai Ke Za Zhi. 2006. PMID: 16784654 Chinese.

3

Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma.

Ding Z, Qian YB, Zhu LX, Xiong QR. Ding Z, et al. Among authors: qian yb. World J Gastroenterol. 2009 Jun 7;15(21):2595-601. doi: 10.3748/wjg.15.2595. World J Gastroenterol. 2009. PMID: 19496188 Free PMC article.

4

Talin1, a valuable marker for diagnosis and prognostic assessment of human hepatocelluar carcinomas.

Zhang JL, Qian YB, Zhu LX, Xiong QR. Zhang JL, et al. Among authors: qian yb. Asian Pac J Cancer Prev. 2011;12(12):3265-9. Asian Pac J Cancer Prev. 2011. PMID: 22471464 Free article.

5

Talin-1 interaction network promotes hepatocellular carcinoma progression.

Chen P, Zheng X, Zhou Y, Xu Y, Zhu L, Qian Y. Chen P, et al. Oncotarget. 2017 Feb 21;8(8):13003-13014. doi: 10.18632/oncotarget.14674. Oncotarget. 2017. PMID: 28099903 Free PMC article.

6

Regulatory mucosa-associated invariant T cells controlled by β1 adrenergic receptor signaling contribute to hepatocellular carcinoma progression.

Fu S, Liu M, Zhu C, Zhang H, Zhao C, Xie Y, Chen G, Sheng D, Pan J, He Z, Dai Y, Gao Y, Li X, Chen L, Qian Y, Jin T, Sun C, Tian Z, Wang H, Bai L. Fu S, et al. Hepatology. 2023 Jul 1;78(1):72-87. doi: 10.1097/HEP.0000000000000014. Epub 2023 Jan 3. Hepatology. 2023. PMID: 36626624

7

Circular RNA circ_0003028 regulates cell development through modulating miR-498/ornithine decarboxylase 1 axis in hepatocellular carcinoma.

Zhang T, Sun Q, Shen C, Qian Y. Zhang T, et al. Anticancer Drugs. 2023 Apr 1;34(4):507-518. doi: 10.1097/CAD.0000000000001457. Epub 2022 Nov 21. Anticancer Drugs. 2023. PMID: 36730287

8

Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling.

Wang D, Zheng X, Fu B, Nian Z, Qian Y, Sun R, Tian Z, Wei H. Wang D, et al. EBioMedicine. 2019 Aug;46:119-132. doi: 10.1016/j.ebiom.2019.07.058. Epub 2019 Jul 30. EBioMedicine. 2019. PMID: 31375423 Free PMC article.

9

MicroRNA-9 is a ponderable index for the prognosis of human hepatocellular carcinoma.

Sun J, Fang K, Shen H, Qian Y. Sun J, et al. Int J Clin Exp Med. 2015 Oct 15;8(10):17748-56. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26770365 Free PMC article.

10

LncRNA TRG-AS1 stimulates hepatocellular carcinoma progression by sponging miR-4500 to modulate BACH1.

Sun X, Qian Y, Wang X, Cao R, Zhang J, Chen W, Fang M. Sun X, et al. Cancer Cell Int. 2020 Aug 4;20:367. doi: 10.1186/s12935-020-01440-3. eCollection 2020. Cancer Cell Int. 2020. PMID: 32774161 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters